800-260-4138
Thank you for requesting a free assessment from Tax Point Advisors. We sincerely appreciate your interest and will be back in touch with you as soon as possible.
In the meantime, please feel free to browse through our most recent blogs found below.
Please also feel free to connect with us on social media: LinkedIn, Facebook and Twitter.
And, for additional questions about R&D tax credits, contact us at any time 800-260-4138.
At first glance, it may seem unlikely that the poultry industry would have much in common with federal and state research and development (R&D) tax credits. After all, for years, R&D tax credits have been associated with large manufacturing, high-tech and medical companies. However, businesses engaged in the poultry industry are ripe with qualifying opportunities for valuable tax credits associated with the activities they conduct for improved products and/or processes.
Consumer demands for fresher products made without artificial colors/flavors, preservatives, hydrogenated fats, or genetically modified ingredients (GMOs) have had a significant impact on the food science industry in recent years. These demands have made research and development a key factor in the productivity and growth of the food industry.
If your company operates in the water treatment industry there is a good chance that you would benefit from the R&D credit.
On July 4, 2025, President Trump signed the “One Big Beautiful Bill Act” (H.R. 1) into law. This sweeping legislation locks in lower tax rates, and restores some valuable incentives for business owners, including 100% Bonus Depreciation, immediate R&D expensing, and the Section 199A Qualified Business Income Deduction.
For business owners, this isn’t just good news–it’s a call to action. The new rules create opportunities to save big before the end of 2025, but only if your tax planning strategy is in place in time.
According to a recent industry report, the U.S. pharmaceutical industry spends more than $100 billion annually on research and development (R&D) activities involving the development, design and testing of new or improved pharmaceutical drugs. Many of these activities qualify for federal and state R&D tax credits; is your company taking advantage of this opportunity to reinvest in the growth of your company?
Software development is often overlooked when it comes to research and development (R&D) tax credits, which is rather ironic when you think about the innovation, creativity and invention that is such an intrinsic part of this industry. Any time your software company makes improvements to products or processes, there is a good chance that your activities may qualify for valuable R&D tax credits that can greatly reduce your tax burden.
